PHARMARESEARCH BIO Co., Ltd. Stock

Equities

A217950

KR7217950005

Biotechnology & Medical Research

End-of-day quote Korea S.E. 18:00:00 2024-05-02 EDT 5-day change 1st Jan Change
30,350 KRW +2.02% Intraday chart for PHARMARESEARCH BIO Co., Ltd. +1.34% +51.00%
Dynamic Chart
PHARMARESEARCH BIO Co., Ltd. announced that it has received KRW 10 billion in funding from Shinhan Capital Co., Ltd. CI
PHARMARESEARCH BIO Co., Ltd. announced that it expects to receive KRW 10 billion in funding from Shinhan Capital Co., Ltd. CI
PHARMA RESEARCH BIO Co., Ltd. announced that it has received KRW 30 billion in funding from PharmaResearch Co., Ltd. CI
PHARMA RESEARCH BIO Co., Ltd. announced that it expects to receive KRW 30 billion in funding from PharmaResearch Co., Ltd. CI
Dongho Song cancelled the acquisition of G Biologics Co., Ltd. from PHARMA RESEARCH BIO Co., Ltd.. CI
Dongho Song agreed to acquire G Biologics Co., Ltd. from PHARMA RESEARCH BIO Co., Ltd. for KRW 5.2 billion. CI
Sangsoo Jung and others acquired 26.2% stake in Pharma Research Bio Co., Ltd. from Dong-Ho Song for KRW 16.5 billion. CI
Dong-Ho Song acquired an additional 0.034% stake in Pharma Research Bio Co., Ltd. from KDB Capital Corp.for KRW 30.5 million. CI
Dong-Ho Song acquired an additional 1.9% stake in Pharma Research Bio Co., Ltd. from KDB Capital Corp.for KRW 1.7 billion. CI
Dong-Ho Song acquired an additional 2.8% stake in Pharma Research Bio Co., Ltd. from Meritz Securities Co., Ltd, Investment Arm for KRW 2.2 billion. CI
Sangsoo Jung and others acquired 26.2% in Pharma Research Bio Co., Ltd. from Dong-Ho Song for KRW 16.5 billion. CI
BIOCND Inc. announced that it has received KRW 10 billion in funding from Pharma Research Products Co., Ltd CI
Pharma Research Products Co., Ltd completed the acquisition of 42.45% stake in BIOCND Inc. from a group of shareholders. CI
BIOCND Inc. announced that it expects to receive KRW 10 billion in funding from Pharma Research Products Co., Ltd CI
Pharma Research Products Co., Ltd signed a memorandum of understanding to acquire 42.45% stake in BIOCND Inc. from a group of shareholders for KRW 25.9 billion. CI
More news
1 day+2.02%
1 week+1.34%
Current month-2.10%
1 month-0.98%
3 months+23.37%
6 months+48.05%
Current year+51.00%
More quotes
1 week
29 000.00
Extreme 29000
32 950.00
1 month
27 250.00
Extreme 27250
32 950.00
Current year
19 610.00
Extreme 19610
32 950.00
1 year
19 020.00
Extreme 19020
32 950.00
3 years
17 050.00
Extreme 17050
45 000.00
5 years
6 170.00
Extreme 6170
45 000.00
10 years
6 170.00
Extreme 6170
45 000.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 59 -
Chief Executive Officer 54 -
Chairman 66 -
Members of the board TitleAgeSince
Director/Board Member 58 22-09-30
Director/Board Member 63 -
Chairman 66 -
More insiders
PharmaResearch Bio Co Ltd, formerly Pharma Research Bio Co Ltd, is a Korea-based company is principally engaged in the research, development and production of biological drugs. The Company is mainly engaged in the research, development and production of botulinum toxin prescription drugs. The Company distributes its products within domestic market and to overseas markets including China and the United Kingdom.
More about the company
  1. Stock Market
  2. Equities
  3. A217950 Stock